Tepha pulls in $3M for medical biomaterials

By Mass High Tech staff

Video Gallery

MHT's Julie Donnelly: Pharmaceuticals find drug development partners in colleges

Funding drugs for rare diseases

MHT's Julie Donnelly: Life science startups finding investments

Spin Transfer whips up $36M in first round [February 13, 2012]

Oxford Immunotec taps Altieri as CFO [February 13, 2012]

SeraCare selling to Linden for $82M [February 13, 2012]

UtiliData finds more funding from Braemer [February 13, 2012]

Tepha Inc., a Lexington-based medical devices company, has raised almost $3 million in financing, according to a regulatory filing with the U.S. Securities and Exchange Commission.

The privately held company makes absorbable biomaterials, including polymers and elastomers, used in medical devices such as surgical sutures and meshes. The company did not disclose its investors in this latest funding round. However, it last reported a $10.7 million financing in 2007, led by The Vertical Group, based in Summit, N.J., with participation from Integra Ventures, Novartis Venture Fund and Westfield Life Sciences Fund.

Tepha was founded in 1998 as a spinoff of a collaboration between its sister company Metabolix Inc. in Cambridge and Children’s Hospital Boston to develop technologies related to cardiac tissue engineering.

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.